earnings (EBITDA). Shareholders, including the majority shareholders, expressed their faith in the performance and future prospects of the Company and subscribed, in large numbers, to the warrants (IVL-W1
earnings (EBITDA). Shareholders, including the majority shareholders, expressed their faith in the performance and future prospects of the Company and subscribed, in large numbers, to the warrants (IVL-W1
remaining two segments, Integrated Oxides & Derivatives and Specialty Chemicals are expected to resume their earnings from unplanned shutdowns, except IPA which we believe will recover over the next 12-18
1,831 (26) (1.4) Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) In 1Q18, the Company has earnings before interest payable, tax, and depreciation (EBITDA) pursuant to the Financial
discharge & complaint SW income for THB 3.7 million. Without this adjustment, administrative expenses would have been decreased by 4%. Earnings before interest, taxes and depreciation (“EBITDA”) EBITDA (not
% 112.68 99.26 14% Earnings before interest tax and deprecation 114.01 80.11 42% 270.02 218.00 24% % Earnings before interest tax and deprecation 29% 25% 4% 26% 24% 2% Other income /(expenses) 5.00 2.84 76
% 986.58 876.62 13% Gross margin 108.76 79.99 36% 417.39 332.84 25% % Gross margin 30% 25% 4% 30% 28% 2% Administrative expenses 40.51 38.10 6% 153.19 137.37 12% Earnings before interest, taxes and
69.76% Total Liabilities 2,728.63 1,850.87 877.75 47.42% Issued and paid-up share capital 333.80 333.80 - - Premium on ordinary shares 587.17 587.17 - - Retained earnings – Appropriated 40.00 36.29 3.71
% Issued and paid-up share capital 80.00 80.00 - - Retain earnings Appropriated-legal reserve 0.10 0.80 0.70 696.44% Details Financial Statements for the year ended 31 December 2017 31 December 2018 Change
of hospital operations 257.36 226.88 13% Gross margin 125.57 86.97 44% % Gross margin 33% 28% 5% Administrative expenses 47.84 35.48 35% Earnings before interest, taxes and depreciation 105.66 75.92 39